Navigation Links
New Hair in 15 Days Could Now Be A Possibility Say Researchers

Adult hair follicles undergo a growth cycle consisting of periods of growth (anagen), regression (catagen), and rest (telogen). Researchers demonstrated that the brief activation of ?-catenin in // telogen-phase adult hair follicles is sufficient to initiate the anagen phase. Scientists have discovered that the transient activation of a protein called ?-catenin can induce new hair growth.

Previous work has implicated Wnt/?-catenin signaling in embryonic hair follicle development, postnatal follicle growth and maturation, and skin tumor formation. This new work provides important insight into the role of ?-catenin as a trigger for activating the normal growth of adult hair follicles.

Researchers generated transgenic mice expressing an inactive version of ?-catenin in their skin and hair follicles. Upon topical treatment of the mice with a chemical called 4-OHT, the exogenous ?-catenin protein is activated. Thus, through the cutaneous application of 4-OHT, the researchers could transiently activate ?-catenin signaling at will.

To test the effect of ?-catenin signaling on adult hair growth, the researchers shaved the backs of telogen-phase transgenic and wild-type mice, and then applied 4-OHT once. Within 15 days, the transgenic mice grew new hair, whereas wild-type still had none . Furthermore, the new hair was histologically indistinguishable from normal hair, and progressed through the remainder of the growth cycle in stereotypical fashion.

It was found that brief activation of ?-catenin in resting hair follicles is sufficient to trigger a normal follicle growth phase, followed by the expected regression and resting phases. ?-catenin acts specifically on epithelial hair follicle progenitor cells, triggering a highly coordinated program of proliferation followed by expansion into the multiple differentiated cell types that comprise the mature, growing hair follicle. In contrast to the effects of transient and regulated beta-cat
'"/>




Page: 1 2

Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Nasal Spray Could Take Drugs Direct to Brain.
3. Nasal Spray Could Take Drugs Directly to Brain
4. Oxygen Usage During Exercise Could Indicate Heart Problems
5. Ultrasound Screening Could Improve The Outcome Of Critically ill Patients
6. Anger Could Be Linked To Weight Gain
7. A Seizure Late In Life Could be A Stroke Warning
8. New Findings Could Reduce The Extent Of Spinal Cord Injuries
9. Could There Be A Link Between Famine and Breast Cancer ?
10. Bone Marrow Cells Could Yield A New Lease of Life
11. Your Wheezing Could be Due To Your Bed
Post Your Comments:
(Date:5/17/2008)... Biggs Named Spokesperson for Education Campaign o...lpha-1 Proteinase Inhibitor (Human) Augmentation ...USSIA, Pa., May 17 /PRNewswire/ -- Melissa Biggs, ...watch was recently named,spokesperson for an educa...ing Americans to get tested for alpha-1 antitrypsi...
(Date:5/16/2008)... BENSALEM, Pa., May 16 /PRNewswire/ -- Law Offi...eadline to move to be a lead plaintiff in the,secu... persons who,purchased or otherwise acquired the c... ("Inverness Medical" or the "Company") (Amex: IM...or about November 14, 2007 (the,"Class Period"). T...
(Date:5/16/2008)...Consumers could report side effects, but critics w...IDAY, May 16 (HealthDay News) -- Direct-to-consume...e phone number that would allow consumers to repor...ted Friday. , The experts serve on a panel that...ch phone numbers are already mandated by the FDA f...
(Date:5/16/2008)... Contract Covers More than 500 Workers, WASHIN...500 paramedics,and emergency medical technicians i...ington area have ratified their first-ever contrac...these workers are now covered by a,strong contract...ement,future," said Teamsters General President Ji...
Breaking Medicine News(10 mins):Health News:Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awareness of Alpha-1 Antitrypsin Deficiency, a Commonly Misdiagnosed Respiratory Disease 2Health News:Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awareness of Alpha-1 Antitrypsin Deficiency, a Commonly Misdiagnosed Respiratory Disease 3Health News:Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awareness of Alpha-1 Antitrypsin Deficiency, a Commonly Misdiagnosed Respiratory Disease 4Health News:Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awareness of Alpha-1 Antitrypsin Deficiency, a Commonly Misdiagnosed Respiratory Disease 5Health News:Law Offices of Howard G. Smith Announces 24 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Inverness Medical Innovations, Inc. 2Health News:FDA Panel Considers Toll-Free Number for TV Drug Ads 2Health News:FDA Panel Considers Toll-Free Number for TV Drug Ads 3
...rd researchers suggests a link between the hepatit...study, people who received the vaccine were three-...hree years than those who were not vaccinated. Whi...tigators emphasize the overall effect of the vacci...
... an increased risk for life-threatening cardiovasc...etes would be well // advised to monitor their blo..., according to a new study. Researchers conducted ...ed observational studies focused on the relationsh...
...itis in asthma patients tends to be more severe an...hers suggest patients // can have dramatic improve...surgical options is used. In the study patients wi...cidence of nasal polyps, olfactory dysfunction, an...
... designed to educate parents about allergens and t...in children // say researchers .More than 900 ch... allergic to at least one indoor environmental all...earch shows children who live in these areas suffe...
Other Medicine News:
(Date:5/16/2008)...6 /- Memory Pharmaceuticals...ith several key development,programs at its R&D Da...ny,reported new clinical data for MEM 1414, its le...S activity in humans. In addition, the,Company has...date from its,5-HT6 antagonist program, and separa...
(Date:5/16/2008)... /- BioVex Inc, a biotechnology,compa...and infectious,disease, announced today that the a...ase II clinical trial of OncoVEX GM-CSF in advance...ican Society of Clinical Oncology,(ASCO) website l...abstract,which describes the data as of the submis...
(Date:5/16/2008)...al Biomarkers -- for Lung Cancer Diagnosis and, Id...er of Unknown Primary ... Types With High Sensitivity and, Specificity an...ancer Results of microRNA Signature to Identify T...eding 90% and Specificity of 99%, REHOVOT, Israel...
(Date:5/16/2008)...Statistically Significant Reductions in Selected ...tract to be published in 2008 Proceedings of the A...cal Oncology, SAN DIEGO, May 16 /PRNewswire-First...X ) announced today that, in a registrational bioe...statistically significant reduction,in general dis...
Breaking Medicine Technology:Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day 2Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day 3Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day 4BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 2BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 3Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 2Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 3Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 4Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 5Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 6ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 2ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 3ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 4ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 5Environment Energy and Ethics conference at UD Sept 21 23 1197 1Environment Energy and Ethics conference at UD Sept 21 23 1197 2Scientists highlight benefits of genetic research in sport but warn of ethical concerns 1194 1Scientists highlight benefits of genetic research in sport but warn of ethical concerns 1194 2Scientists highlight benefits of genetic research in sport but warn of ethical concerns 1194 3Salmon garnish points the way to green electronics 377 1Salmon garnish points the way to green electronics 377 2Salmon garnish points the way to green electronics 377 3Academy releases emergency preparedness tools to enable millions more people to shelter in place 1191 1Academy releases emergency preparedness tools to enable millions more people to shelter in place 1191 2Academy releases emergency preparedness tools to enable millions more people to shelter in place 1191 3Academy releases emergency preparedness tools to enable millions more people to shelter in place 1191 4
...udy shows intramuscular injection of peramivir for...nza virus infection and,inhibited virus replicatio...uenza during a pandemic, MEMPHIS, Tenn., May 01, 2...peramivir might offer humans significant protectio...5N1, according to,results of mouse studies conduct...
...ivotal phase III study in women with recurrent ova...GTON, May 01, 2007,/PRNewswire-FirstCall/ -- A new...tion of phenoxodiol, an investigational drug being...drug appears to,work by targeting a certain tumor-...s that selectively induce cancer cell death.,Pheno...
Other Medicine Technology:Peramivir Protects Mice From Lethal H5N1 Infection 2Peramivir Protects Mice From Lethal H5N1 Infection 3New Research Results Show That Investigational Drug Phenoxodiol,Targets Cancer Protein, Causing Cancer Cell Death 2New Research Results Show That Investigational Drug Phenoxodiol,Targets Cancer Protein, Causing Cancer Cell Death 3New Research Results Show That Investigational Drug Phenoxodiol,Targets Cancer Protein, Causing Cancer Cell Death 4New Research Results Show That Investigational Drug Phenoxodiol,Targets Cancer Protein, Causing Cancer Cell Death 5
Provides stable positioning of the knee during surgery.
The kneeGRIP™ is designed to secure the position of the lower extremity with the knee flexed.
The autoLog™ Autotransfusion System processes blood collected from a surgical site to produce washed red blood cells for return to a patient at a later time. This is achieved with only one kit
...cs OrthoPAT system collects and cleanses red blood...e first product of its kind designed specifically ...loss of orthopedic surgical patients. The system c...an electromechanical device which together collect...
Medicine Products: